>The company themselves admitted they got lucky with this indication, in that the rapid clearance is probably more beneficial.<
Actually, it was Dr. Meade who said this and he was expressing his personal opinion. He also said in the same session that GTC could have modified the ATryn glycosylation pattern if they had needed to.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”